妊娠期糖尿病临床治疗体会及对母婴结局的影响
2020-11-06杜艳华
杜艳华


【摘要】 目的:分析妊娠期糖尿病临床治疗及对母婴结局的影响。方法:选择2018年10月-2019年10月笔者所在医院收治的74例妊娠期糖尿病患者,行常规药物治疗的37例为普通组,增加饮食、运动治疗的37例为综合组,观察两组血糖水平及母婴结局。结果:综合组PBG水平为(5.73±1.29)mmol/L,HbA1c水平为(6.21±1.47)%,2 h PG水平为(9.36±2.51)mmol/L,均低于普通组的(7.24±1.63)mmol/L、(7.71±1.22)%、(11.47±2.03)mmol/L,差异均有统计学意义(P<0.05)。综合组不良妊娠结局发生率为13.51%,低于普通组的35.14%,差异有统计学意义(P<0.05)。综合组新生儿不良结局发生率为8.11%,低于普通组的27.02%,差异有统计学意义(P<0.05)。结论:给予妊娠期糖尿病患者药物、饮食及运动治疗,可有效恢复血糖水平,改善母婴结局,推广使用价值较高。
【关键词】 妊娠期糖尿病 母婴结局 临床治疗
doi:10.14033/j.cnki.cfmr.2020.22.067 文献标识码 B 文章编号 1674-6805(2020)22-0-03
[Abstract] Objective: To analyze the clinical treatment of gestational diabetes mellitus and its effect on maternal and infant outcomes. Method: A total of 74 patients with gestational diabetes mellitus who were treated in our hospital from October 2018 to October 2019 were selected. And 37 patients who received conventional drug treatment were selected as the general group, and 37 patients who increased diet and exercise therapy were selected as the comprehensive group. The blood glucose levels and maternal and infant outcomes were observed between the two groups. Result: In the comprehensive group, the PBG level was (5.73±1.29) mmol/L, the HbA1c level was (6.21±1.47)%, the 2 h PG level was (9.36±2.51) mmol/L, which were lower than (7.24±1.63) mmol/L, (7.71±1.22)% and (11.47±2.03) mmol/L of the general group, and the differences were significant (P<0.05). The incidence of adverse pregnancy outcome in the comprehensive group was 13.51%, which was lower than 35.14% of the general group, and the difference was significant (P<0.05). The incidence of neonatal adverse outcomes in the comprehensive group was 8.11%, which was lower than 27.02% of the general group, and the difference was significant (P<0.05). Conclusion: Drug, diet and exercise therapy for patients with gestational diabetes mellitus can effectively restore blood glucose levels, and improve the maternal and infant outcomes. The value of promotion and use is high.
[Key words] Gestational diabetes mellitus Maternal and infant outcomes Clinical treatment
First-authors address: Maternal and Child Health Hospital in Qujing, Qujing 655000, China
妊娠期糖尿病是女性在妊娠期出現的血糖水平异常升高的疾病,诱发因素较多,包括饮食、肥胖、家族病史等。近年来,妊娠期糖尿病发病率显著上升,对母婴结局产生严重负面影响[1-3]。为改善母婴结局,临床通常将控制血糖作为治疗关键点。本研究主要分析妊娠期糖尿病临床治疗及对母婴结局的影响,选取2018年10月-2019年10月笔者所在医院收治的74例妊娠期糖尿病患者为观察对象,报道如下。
1 资料与方法
1.1 一般资料
选取2018年10月-2019年10月笔者所在医院收治的74例妊娠期糖尿病患者。妊娠期糖尿病诊断标准:(1)妊娠期空腹血糖水平>5.1 mmol/L,餐后2 h血糖水平>11.1 mmol/L,且检测次数≥2次;空腹状态下,常规尿液检验结果提示酮体、尿蛋白、尿糖为阳性。(2)口服75 g葡萄糖,空腹(5.1 mmol/L)、餐后1 h(10.0 mmol/L)、餐后2 h(8.5 mmol/L)血糖水平中任一项升高。纳入标准:确诊为妊娠期糖尿病;依从性较高。排除标准:肝肾功能异常;精神类疾病;甲状腺疾病。依据治疗方法分为两组,每组37例。普通组年龄22~38岁,平均(29.14±3.68)岁;孕周24~36周,平均(28.13±1.57)周;初产妇21例,经产妇16例。综合组年龄21~39岁,平均(30.08±3.94)岁;孕周25~35周,平均(27.14±1.39)周;初产妇19例,经产妇18例。两组……
